Market Analysis and Insights: Global IVIG Market
The global IVIG market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global IVIG Scope and Market Size
The global IVIG market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global IVIG market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Injection IVIG
Lyophilized Powder IVIG

Segment by Application
Multiple Sclerosis(MS)
Myasthenia Gravis(MG)
Multifocal Motor Neuropathy(MMN)
Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
Dermatomyositis
Polymyositis

The IVIG market is analysed and market size information is provided by regions (countries). Segment by Application, the IVIG market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Green Cross
BSV
Hualan Bio
RAAS
YUAN DA SHUYANG
Kangbao Bio
Tiantan Bio
Taibang Bio
Weiguang Bio
SIBP
TONROL
RUIDE Bio
BOYA Bio
RUIDE Bio
Xinxing Medicine
Weilun Bio
WIBP